{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:25:38Z","timestamp":1787102738856,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Natural Science Key Project of Anhui Provincial Department of Education"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-026-00439-5","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:46:05Z","timestamp":1781282765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fibrillin-1 alleviates high glucose-induced fibroblast apoptosis and inflammation via autophagy activation"],"prefix":"10.1038","volume":"16","author":[{"given":"Ya","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7729-8189","authenticated-orcid":false,"given":"Shujuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"439_CR1","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1002\/1520-7560(200009\/10)16:1+<::AID-DMRR113>3.0.CO;2-S","volume":"16","author":"J Apelqvist","year":"2000","unstructured":"Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000;16:S84\u201392.","journal-title":"Diabetes Metab Res Rev"},{"key":"439_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1067-2516(07)60001-5","volume":"45","author":"RG Frykberg","year":"2006","unstructured":"Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45:S1\u201366.","journal-title":"J Foot Ankle Surg"},{"key":"439_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137\u201349.","journal-title":"Diabetes Res Clin Pract"},{"key":"439_CR4","doi-asserted-by":"crossref","unstructured":"Papanas N, Maltezos E. Etiology, pathophysiology and classifications of the diabetic Charcot foot. Diabet Foot Ankle. 2013;4.","DOI":"10.3402\/dfa.v4i0.20872"},{"key":"439_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1172\/JCI32169","volume":"117","author":"H Brem","year":"2007","unstructured":"Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117:1219\u201322.","journal-title":"J Clin Invest"},{"key":"439_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"N Singh","year":"2005","unstructured":"Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217\u201328.","journal-title":"JAMA"},{"key":"439_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3266","volume":"36","author":"NC Schaper","year":"2020","unstructured":"Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36:e3266.","journal-title":"Diabetes Metab Res Rev"},{"key":"439_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11136-006-0031-y","volume":"16","author":"L Ribu","year":"2007","unstructured":"Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res. 2007;16:179\u201389.","journal-title":"Qual Life Res"},{"key":"439_CR9","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","volume":"366","author":"AJ Boulton","year":"2005","unstructured":"Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366:1719\u201324.","journal-title":"Lancet"},{"key":"439_CR10","first-page":"187","volume":"18","author":"MP Moutschen","year":"1992","unstructured":"Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab. 1992;18:187\u2013201.","journal-title":"Diabete Metab"},{"key":"439_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00125-002-0868-8","volume":"45","author":"R Lobmann","year":"2002","unstructured":"Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002;45:1011\u20136.","journal-title":"Diabetologia"},{"key":"439_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.vph.2012.06.004","volume":"57","author":"R Ramasamy","year":"2012","unstructured":"Ramasamy R, Yan SF, Schmidt AM. The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vascul Pharmacol. 2012;57:160\u20137.","journal-title":"Vascul Pharmacol"},{"key":"439_CR13","doi-asserted-by":"publisher","first-page":"BSR20210640","DOI":"10.1042\/BSR20210640","volume":"42","author":"FC Song","year":"2022","unstructured":"Song FC, Yuan JQ, Zhu MD, Li Q, Liu SH, Zhang L. High glucose represses the proliferation of tendon fibroblasts by inhibiting autophagy activation in tendon injury. Biosci Rep. 2022;42:BSR20210640.","journal-title":"Biosci Rep"},{"key":"439_CR14","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","volume":"96","author":"L Pereira","year":"1999","unstructured":"Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA 1999;96:3819\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"439_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ygeno.2003.08.023","volume":"83","author":"GM Corson","year":"2004","unstructured":"Corson GM, Charbonneau NL, Keene DR, Sakai LY. Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues. Genomics. 2004;83:461\u201372.","journal-title":"Genomics"},{"key":"439_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.bbamcr.2009.01.012","volume":"1793","author":"M Chiquet","year":"2009","unstructured":"Chiquet M, Gelman L, Lutz R, Maier S. From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Biophys Acta. 2009;1793:911\u201320.","journal-title":"Biochim Biophys Acta"},{"key":"439_CR17","doi-asserted-by":"publisher","first-page":"e86295","DOI":"10.1371\/journal.pone.0086295","volume":"9","author":"Y Shi","year":"2014","unstructured":"Shi Y, Wang Y, Luan W, Wang P, Tao T, Zhang J, et al. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One. 2014;9:e86295.","journal-title":"PLoS One"},{"key":"439_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10735-021-09996-8","volume":"52","author":"D Han","year":"2021","unstructured":"Han D, Liu W, Li G, Liu L. Circ_PRKDC knockdown promotes skin wound healing by enhancing keratinocyte migration via miR-31\/FBN1 axis. J Mol Histol. 2021;52:681\u201391.","journal-title":"J Mol Histol"},{"key":"439_CR19","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900076RRRRR","volume":"35","author":"B Li","year":"2021","unstructured":"Li B, Zhou Y, Chen J, Wang T, Li Z, Fu Y, et al. Long noncoding RNA H19 acts as a miR-29b sponge to promote wound healing in diabetic foot ulcer. FASEB J. 2021;35:e20526.","journal-title":"FASEB J"},{"key":"439_CR20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature06639","volume":"451","author":"N Mizushima","year":"2008","unstructured":"Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008;451:1069\u201375.","journal-title":"Nature"},{"key":"439_CR21","first-page":"6768","volume":"17","author":"XX He","year":"2018","unstructured":"He XX, Huang CK, Xie BS. Autophagy inhibition enhanced 5\u2011FU\u2011induced cell death in human gastric carcinoma BGC\u2011823 cells. Mol Med Rep. 2018;17:6768\u201376.","journal-title":"Mol Med Rep"},{"key":"439_CR22","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/iid3.492","volume":"9","author":"X Xie","year":"2021","unstructured":"Xie X, Zhong R, Luo L, Lin X, Huang L, Huang S, et al. The infection characteristics and autophagy defect of dermal macrophages in STZ-induced diabetic rats skin wound Staphylococcus aureus infection model. Immun Inflamm Dis. 2021;9:1428\u201338.","journal-title":"Immun Inflamm Dis"},{"key":"439_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omac011","volume":"2022","author":"L Jacobs","year":"2022","unstructured":"Jacobs L, Salif A, Calderon Plazarte V, Alcan I, Taghavi M. Iatrogenic obstructive acute kidney injury due to suprapubic catheterization. Oxf Med Case Reports. 2022;2022:omac011.","journal-title":"Oxf Med Case Reports"},{"key":"439_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46657-z","volume":"9","author":"G Runwal","year":"2019","unstructured":"Runwal G, Stamatakou E, Siddiqi FH, Puri C, Zhu Y, Rubinsztein DC. LC3-positive structures are prominent in autophagy-deficient cells. Sci Rep. 2019;9:10147.","journal-title":"Sci Rep"},{"key":"439_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida I, Ueno T, Kominami E. LC3 and Autophagy. Methods Mol Biol. 2008;445:77\u201388.","journal-title":"Methods Mol Biol"},{"key":"439_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4161\/auto.7.3.14487","volume":"7","author":"T Johansen","year":"2011","unstructured":"Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy. 2011;7:279\u201396.","journal-title":"Autophagy"},{"key":"439_CR27","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"DG Armstrong","year":"2017","unstructured":"Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376:2367\u201375.","journal-title":"N Engl J Med"},{"key":"439_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2337\/dc13-2176","volume":"37","author":"JB Rice","year":"2014","unstructured":"Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37:651\u20138.","journal-title":"Diabetes Care"},{"key":"439_CR29","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(05)67700-8","volume":"366","author":"V Falanga","year":"2005","unstructured":"Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366:1736\u201343.","journal-title":"Lancet"},{"key":"439_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000520333","volume":"13","author":"MA Ovali","year":"2022","unstructured":"Ovali MA, Bozgeyik I. Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the FBN1 Gene, in Health and Disease. Mol Syndromol. 2022;13:175\u201383.","journal-title":"Mol Syndromol"},{"key":"439_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00441-009-0822-x","volume":"339","author":"F Ramirez","year":"2010","unstructured":"Ramirez F, Sakai LY. Biogenesis and function of fibrillin assemblies. Cell Tissue Res. 2010;339:71\u201382.","journal-title":"Cell Tissue Res"},{"key":"439_CR32","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1074\/jbc.M806962200","volume":"284","author":"L Carta","year":"2009","unstructured":"Carta L, Smaldone S, Zilberberg L, Loch D, Dietz HC, Rifkin DB, et al. p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J Biol Chem. 2009;284:5630\u20136.","journal-title":"J Biol Chem"},{"key":"439_CR33","doi-asserted-by":"publisher","first-page":"13874","DOI":"10.1074\/jbc.M707820200","volume":"283","author":"G Sengle","year":"2008","unstructured":"Sengle G, Charbonneau NL, Ono RN, Sasaki T, Alvarez J, Keene DR, et al. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem. 2008;283:13874\u201388.","journal-title":"J Biol Chem"},{"key":"439_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27\u201342.","journal-title":"Cell"},{"key":"439_CR35","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728\u201341.","journal-title":"Cell"},{"key":"439_CR36","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1101\/gad.17558811","volume":"25","author":"AC Kimmelman","year":"2011","unstructured":"Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev. 2011;25:1999\u20132010.","journal-title":"Genes Dev"},{"key":"439_CR37","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","volume":"17","author":"RK Amaravadi","year":"2011","unstructured":"Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011;17:654\u201366.","journal-title":"Clin Cancer Res"},{"key":"439_CR38","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1074\/jbc.M110.202911","volume":"286","author":"J Harris","year":"2011","unstructured":"Harris J, Hartman M, Roche C, Zeng SG, O\u2019Shea A, Sharp FA, et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 2011;286:9587\u201397.","journal-title":"J Biol Chem"},{"key":"439_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nri.2016.100","volume":"16","author":"K Cadwell","year":"2016","unstructured":"Cadwell K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat Rev Immunol. 2016;16:661\u201375.","journal-title":"Nat Rev Immunol"},{"key":"439_CR40","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.chom.2009.05.016","volume":"5","author":"V Deretic","year":"2009","unstructured":"Deretic V, Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe. 2009;5:527\u201349.","journal-title":"Cell Host Microbe"},{"key":"439_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrm3735","volume":"15","author":"G Marino","year":"2014","unstructured":"Marino G, Niso-Santano M, Baehrecke EH, Kroemer G. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15:81\u201394.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"439_CR42","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/diacare.27.3.813","volume":"27","author":"JC Pickup","year":"2004","unstructured":"Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27:813\u201323.","journal-title":"Diabetes Care"},{"key":"439_CR43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s10495-008-0307-5","volume":"14","author":"A Eisenberg-Lerner","year":"2009","unstructured":"Eisenberg-Lerner A, Kimchi A. The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis. 2009;14:376\u201391.","journal-title":"Apoptosis"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00439-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00439-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00439-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:57:44Z","timestamp":1787101064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00439-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1038\/s41387-026-00439-5","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Prior to sample collection, informed consent was obtained from the donors adhering to the ethical guidelines outlined in the 1975 Declaration of Helsinki. This study was approved by the Ethic Committee of our institution.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"31"}}